The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Highlights, Pearls & News from ACR Convergence 2020

Highlights, Pearls & News from ACR Convergence 2020

March 15, 2021 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Anton_Medvedev / shutterstock.com

Anton_Medvedev / shutterstock.com

ACR CONVERGENCE 2020—In a year like no other, the 2020 virtual ACR Convergence was a meeting like no other. Nonetheless, the meeting introduced a healthy mix of clinical insights and take-home pearls, according to panelists in the meeting’s closing session, Bright Future: Discovery & Growth. 

You Might Also Like
  • ACR Convergence 2020 Kicks Off: Plenary session speakers highlight racial differences in lupus & COVID-19-related findings
  • View On-Demand Sessions & Content from ACR Convergence 2020
  • ACR Convergence 2020: Study Data for Lupus & Rheumatoid Arthritis
Explore This Issue
March 2021
Also By This Author
  • Study Looks at Cryoglobulin Detection & Immunological Characteristics

In this session, panelists discussed some of the biggest news from ACR Convergence 2020 and how the virtual format compared with the traditional annual meeting. The virtual format attracted 16,000 attendees from 119 countries, said Gregg Silverman, MD, a professor in the departments of medicine and pathology at New York University Grossman School of Medicine. There were up to 7,000 attendees online during any given time, he added. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Here are some of the meeting highlights discussed during the closing session. 

COVID-19 

Dr. Silverman

Dr. Silverman

With all eyes on COVID-19 for obvious reasons, ACR Convergence provided several updates on the disease and its connections to rheuma­tology. Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, presented a pre­recorded session with a COVID-19 overview, and the ACR presented him with the inaugural Distinguished Global Public Health Award. Various presenters covered COVID-19 as it relates to health disparities, lung inflammation, hydroxychloroquine, vaccines and telemedicine. 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One important COVID-19-related presentation, according to Dr. Silverman, was that from Yu Zuo, MD, an assistant professor with Michigan Medicine at the University of Michigan, Ann Arbor. His research focused on the measurement of pathogenic autoantibodies in hospitalized patients with COVID-19. Researchers

Dr. Kamen

Dr. Kamen

examined sera from 172 patients for eight types of autoantibodies, including anti-cardiolipin IgG/IgM/IgA, anti-beta-2 glycoprotein I IgG/IgM/IgA and anti-phosphatidylserine/prothrombin IgG/IgM antibodies. Anti-cardiolipin IgM antibodies were found in 23% of COVID-19 patients, anti-phosphatidylserine/prothrombin IgG antibodies in 24% and anti-phosphatidylserine/prothrombin IgM antibodies in 18%. Higher levels were usually associated with more severe COVID-19. 

Lupus 

Although 2020 was not a great year overall, it actually was a great year for lupus research, said panelist Diane Kamen, MD, MSCR, an associate professor of medicine at Medical University of South Carolina, Charleston. Several ACR Convergence presenters shared study results related to new potential treatments for lupus, she said. This included data about anifrolumab, which was part of the Phase 3 TULIP-1 and TULIP-2 trials and discussed in a plenary session from Richard A. Furie, MD, a professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Great Neck, New York, as well as several other presenters. Anifrolumab is a fully human monoclonal antibody that binds to subunit 1 of the type 1 interferon receptor. 

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis, SLE (Lupus) Tagged With: ACR Convergence 2020, COVID-19, DietIssue: March 2021

You Might Also Like:
  • ACR Convergence 2020 Kicks Off: Plenary session speakers highlight racial differences in lupus & COVID-19-related findings
  • View On-Demand Sessions & Content from ACR Convergence 2020
  • ACR Convergence 2020: Study Data for Lupus & Rheumatoid Arthritis
  • Dr. Blair Solow’s Picks for the Top RA Research Presented at ACR Convergence 2020

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)